BioCentury | Mar 14, 2011
Clinical News

GO-203-2c regulatory update

...to oligomerize is in Phase I testing to treat advanced solid tumors, including pancreatic cancer. Genus Oncology LLC...
BioCentury | Feb 21, 2011
Clinical News

Go-203-2c: Phase I started

...once-daily IV Go-203-2c for 3 weeks in a 4-week cycle in up to 40 patients. Genus Oncology LLC...
Items per page:
1 - 2 of 2
BioCentury | Mar 14, 2011
Clinical News

GO-203-2c regulatory update

...to oligomerize is in Phase I testing to treat advanced solid tumors, including pancreatic cancer. Genus Oncology LLC...
BioCentury | Feb 21, 2011
Clinical News

Go-203-2c: Phase I started

...once-daily IV Go-203-2c for 3 weeks in a 4-week cycle in up to 40 patients. Genus Oncology LLC...
Items per page:
1 - 2 of 2